Administrative Core A
Administrative Core A
批准号:
10891051
负责人:
DAVID S METZGER
金额:
$24.38万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-15 至 2025-01-31
关键词:
Acquired Immunodeficiency SyndromeAddressAdvisory CommitteesAreaAwardBasic ScienceBehavioralBehavioral MechanismsBehavioral SciencesBiologicalBiological Specimen BanksBudgetsBusinessesCareer MobilityCharacteristicsCollaborationsCommunicationCommunitiesCommunity OutreachDevelopmentEducationEducation and OutreachEnsureEnvironmentEpidemiologyEquipment and SuppliesEvaluationFosteringFundingFutureHIVHIV riskHIV therapyHIV/AIDSHuman ResourcesIncidenceIndividualInfectionInformation DisseminationInternationalInvestmentsJointsLaboratoriesLeadershipMedicalMental HealthMental disordersMentorsMissionModelingMonitorNational Institute of Mental HealthOutcomeParticipantPediatric HospitalsPennsylvaniaPerformancePersonsPhiladelphiaPlayPoliciesProceduresProcessResearchResearch ActivityResearch DesignResearch InfrastructureResearch PersonnelResearch PriorityResearch SupportResearch TrainingResource SharingResourcesRoleSafetySchoolsScientistSeriesSocial SciencesStrategic PlanningStructureTrainingUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesWomanWorkbehavioral and social sciencebiobehaviorcareer developmentco-infectioncohesioncollaborative environmentcollaboratorycommunity engagementcomorbiditycostdiversity and inclusionexperienceimplementation scienceimprovedinnovationinterdisciplinary collaborationlensmeetingsnext generationorganizational structureoutreachoutreach programprogramspsychologicsoundsynergism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CORE A: Abstract/Summary
Core A provides leadership, management, organizational structure, fiscal oversight, and scientific direction to
the Penn Mental Health AIDS Research Center (PMHARC), enabling it to fulfill its core mission to transform how
people with both mental illness and HIV are treated and managed, an explicit focus not currently pursued by any
other NIMH AIDS Research Center (ARC). PMHARC is unique in: 1) its scientific focus on mental health issues
in HIV through an integration of basic, biological and social and behavioral sciences; 2) its unique behavioral
and specimen repository and status as the only Behavioral ARC with a Laboratory and Biobehavioral Markers
Core; 3) its development of a successful co-funding model with CFAR for PMHARC pilots; and 4) its status as
the only NIMH Behavioral ARC collaborating with the NIMH Neuro ARCs in the NIMH Joint Seminar Series. The
Center and Core A is led by a Director and two Co-Directors with exceptional and complementary strengths and
experience in administration, research, and training and in the study of comorbid mental illness/HIV. PMHARC
is located in an optimal intellectual and resource environment, which encompasses robust and well-regarded
mental health and HIV research communities on the Penn/CHOP/Wistar contiguous campuses. Through Core
A, PMHARC will continue to optimize psychiatric, behavioral, and medical outcomes for those with comorbid
mental illness/HIV and elucidate the biological, psychological, and behavioral mechanisms underlying these
combined illnesses and treatments. Core A has created an interactive environment that fosters communication,
collaboration, and synergy among Center components and participants, as well as with the relevant schools,
departments, centers, and institutes at Penn/CHOP/Wistar including CFAR, CTSA, Delaney Collaboratories at
Wistar and Temple, and other ARCs. Core A will be engaged and responsible for: 1) coordinating interdisciplinary
and collaborative mental health/HIV research; 2) encouraging, supporting, and mentoring new, established, and
transitional investigators to focus on comorbid mental illness/HIV, and related comorbidities; 3) developing
vibrant and responsive Strategic Planning, Monitoring, and Evaluation Processes and comprehensive Policies
and Procedures; 4) managing fiscal matters; 5) conducting educational and community outreach programs; 6)
fostering national linkages among other ARCs; and 7) supporting an active Community Advisory Board (CAB).
Core A also includes 3 Consultants, Executive Committee (EC), Internal Advisory Board (IAB), External Advisory
Committee (EAC), Research Innovation and Diversity Committee (RIDC), and CAB. This structure is explicitly
intended to allow for continuous monitoring and evaluation in order to optimize efficiencies and responsiveness.
In its first two cycles, PMHARC has made impressive progress in: advancing Diversity/ Inclusion; engaging
investigators in combined HIV/mental health research and promoting research infrastructure; identifying,
mentoring, and promoting career advancement of Early Stage Investigators (ESIs); and producing an impressive
return on investment of the pilot award program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
-
批准号:10197865
-
项目类别:
-
资助金额:$167.85万
-
财政年份:2019
-
负责人:DAVID S METZGER
-
依托单位:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
-
批准号:10436808
-
项目类别:
-
资助金额:$165.25万
-
财政年份:2019
-
负责人:DAVID S METZGER
-
依托单位:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
-
批准号:10654008
-
项目类别:
-
资助金额:$162.12万
-
财政年份:2019
-
负责人:DAVID S METZGER
-
依托单位:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
-
批准号:10004224
-
项目类别:
-
资助金额:$51.51万
-
财政年份:2019
-
负责人:DAVID S METZGER
-
依托单位:
Rapid initiation of buprenorphine/naloxone to optimize MAT utilization in Philadelphia
-
批准号:9896726
-
项目类别:
-
资助金额:$74.62万
-
财政年份:2018
-
负责人:DAVID S METZGER
-
依托单位:
Core B: Developmental core
-
批准号:10090663
-
项目类别:
-
资助金额:$43.91万
-
财政年份:2013
-
负责人:DAVID S METZGER
-
依托单位:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
-
批准号:7835556
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2009
-
负责人:DAVID S METZGER
-
依托单位:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
-
批准号:8261981
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2009
-
负责人:DAVID S METZGER
-
依托单位:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
-
批准号:7687184
-
项目类别:
-
资助金额:$36.86万
-
财政年份:2009
-
负责人:DAVID S METZGER
-
依托单位:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
-
批准号:8085908
-
项目类别:
-
资助金额:$30.25万
-
财政年份:2009
-
负责人:DAVID S METZGER
-
依托单位:
Behavioral & Social Sciences
-
批准号:7684973
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2009
-
负责人:DAVID S METZGER
-
依托单位:
Core--Behavioral & Social Sciences Facility
-
批准号:7650391
-
项目类别:
-
资助金额:$21.57万
-
财政年份:2008
-
负责人:DAVID S METZGER
-
依托单位:
Core--Behavioral & Social Sciences Facility
-
批准号:7456546
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2007
-
负责人:DAVID S METZGER
-
依托单位:
Penn prevention clinical trials unit
-
批准号:7560047
-
项目类别:
-
资助金额:$61.33万
-
财政年份:2007
-
负责人:DAVID S METZGER
-
依托单位:
Penn prevention clinical trials unit
-
批准号:7341139
-
项目类别:
-
资助金额:$156.85万
-
财政年份:2007
-
负责人:DAVID S METZGER
-
依托单位:
Penn prevention clinical trials unit
-
批准号:8414863
-
项目类别:
-
资助金额:$60.66万
-
财政年份:2007
-
负责人:DAVID S METZGER
-
依托单位:
Penn prevention clinical trials unit
-
批准号:7098383
-
项目类别:
-
资助金额:$122.86万
-
财政年份:2007
-
负责人:DAVID S METZGER
-
依托单位:
Penn prevention clinical trials unit
-
批准号:8007378
-
项目类别:
-
资助金额:$62.28万
-
财政年份:2007
-
负责人:DAVID S METZGER
-
依托单位:
Penn prevention clinical trials unit
-
批准号:8208122
-
项目类别:
-
资助金额:$61.63万
-
财政年份:2007
-
负责人:DAVID S METZGER
-
依托单位:
Penn prevention clinical trials unit
-
批准号:7751226
-
项目类别:
-
资助金额:$60.82万
-
财政年份:2007
-
负责人:DAVID S METZGER
-
依托单位:
海外基金